global statin market 2015-2019
TRANSCRIPT
USA – CANADA – UK – CHINA – INDIA
Global Statin Market 2015-2019
The report discusses the following in-depth:
• Market Size and Forecast
• Market Segmentation
• Buying Criteria
• Vendor Landscape
• Business Segmentation
• Geographical Segmentation
For more information on the
Global Statin Market 2015-2019,
please mail us [email protected]
USA – CANADA – UK – CHINA – INDIA
Key Trends
Technavio’s Senior Analyst says, “The rising incidences of high cholesterol and dyslipidemia are one of the main drivers in this market. These lipid metabolic disorders are associated with over half the global cases of coronary heart disease and related deaths. Statins can lower cholesterol and are thus in demand. Another major driver is the introduction of OTC versions of statins by major vendors. These drugs are cheaper and more affordable for the treatment-seeking population.”
• Statin is a structural analog of HMG-CoA enzyme and is effective in reducing LDL. It shows its pharmaceutical action by inhibiting the key enzyme involved in cholesterol synthesis, which is called HMG-CoA reductase. Therefore, statin is referred to HMG-CoA reductase inhibitors. Statin has been associated with a beneficial effect on cardiovascular morbidity and mortality.
• Technavio's analysts forecast the global statin market to decline at a CAGR of 7.50% over the period 2014-2019.
• Understanding the key drivers influencing the market
• Understanding the challenges faced by the market
• Activities of various stakeholders involved
• Key focus areas for the vendors
• Major trends that will shape the future of this market
• Vendor landscape and trajectory of the market
• Conclusion
Scope of The Report
A detailed analysis of each market driver, challenge
and trend isavailable in our report:
Global Statin Market 2015-2019
USA – CANADA – UK – CHINA – INDIA
USA – CANADA – UK – CHINA – INDIA
Vendors
To understand the vendor landscape and
for a full list of vendors view our report:
Global Statin Market 2015-2019
AstraZeneca
Merck
Novartis
AstraZeneca plc is a global biopharmaceutical company and is involved in the discovery, development, and commercialization of medicines for various segments such as Cardiovascular and Metabolic Disease; Oncology; Respiratory, Inflammation, and Autoimmunity; and Infection, Neuroscience, and Gastrointestinal Disease.
Merck & Co. Inc. is a global healthcare company specialized in delivering various health solutions through its prescription medicines, vaccines, biologic therapies, animal healthcare products, and consumer care products.
Novartis carries out the research, development, and manufacturing of prescription and generic pharmaceuticals, vaccines, and consumer health products. The company sells these products in various countries that are classified by the company into three reportable regions, the Americas, Europe, and Asia/Africa/Australasia.
USA – CANADA – UK – CHINA – INDIA
Market Landscape
• The global statin market is expected to decline at a moderate rate during the forecast period because of the expiry of the patent exclusivity of the major branded drugs in the market.
• Undesirable side effects and the high cost of therapy, which reduce the number of treatment-seeking patients, are also responsible for the negative growth of the market.
• However, an increase in the prevalence of chronic disease worldwide and expected entry of cost-effective OTC versions of prescription drugs are expected to offset the growth of the market.
• The market is dominated by AstraZeneca, Merck, Novartis, and Pfizer.
USA – CANADA – UK – CHINA – INDIA
Key Buying Criteria
Parameter Details
Affordability Statins should be affordable and priced reasonably.
Availability Statins should be readily available in the market.
Efficacy Statins should be efficient and show positive results.
Safety Statins should be safe and have minimum adverse effects.
• Growth Forecasts?
• Market Analysis?
• Revenue Forecasts?
• Regional and Country level Analysis?
• Competitive Structure?
• Emerging Trends?
• Vendor Landscape?
• Other?
What Would You Like to Learn From Technavio?
Global Statin Market 2015-2019
Let us identify your needs.We would love to hear more!
USA – CANADA – UK – CHINA – INDIA
Our Report Covers: Market Scenarios, Vendor landscape & Industry Road Maps.
You have the Option to Customize Reports & Access Analysts on every Report Purchase.
Purchasing this report?
For media enquiries,please drop us a mail at
We’ll include an hour with our analysts to discuss the report findings.
For free.
USA – CANADA – UK – CHINA – INDIA
Access the Report
USA – CANADA – UK – CHINA – INDIA
India: An Overview
USA – CANADA – UK – CHINA – INDIA
About Us
USA – CANADA – UK – CHINA – INDIA
Thank You!
North America
Chicago, USA
Phone: +1 630 333 9501
Fax: +1 630 833 2171
Europe
London, United Kingdom
Phone: +44 208 123 1770
Fax: +44 845 280 2825
Asia
Bangalore, India
Phone: +91 934 254 0560
Fax: +91 80 4080 6070
DISCLAIMER
This presentation is intended solely for showcasing Infiniti’s research capabilities. All information contained within this presentation has been randomized and should not be used for any kind of analysis and/or for decision making purpose. All trademarks and copyrights remain the sole ownership of their rightful owners/licensees. In no event shall
Infiniti Research have any liability to any party for special, incidental, tort, or consequential damages arising out of or in connection with this report, even if Infiniti Research has been advised of the possibility of such damages.
Copyright ©2013 Infiniti Research Limited. All Rights Reserved.
Reproduction without written permission is completely forbidden.
NOT FOR FURTHER DISTRIBUTION